Enrollment and Randomization of 12463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial - P&T Community Get link Facebook X Pinterest Email Other Apps November 21, 2019 Enrollment and Randomization of 12463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial P&T Community Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment